Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia

Brain

Volumn 126, Issue 4, 2003, Pages 814-826

  Stanford, Prudence M ^a   Shepherd, Claire E ^b,c   Halliday, Glenda M ^b,g   Brooks, William S ^c   Schofield, Peter W ^e   Brodaty, Henry ^d   Martins, Ralph N ^f   Kwok, John B J ^a   Schofield, Peter R ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^g NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Apoptosis; Four repeat tau; Frontotemporal dementia; Tau gene mutation; Three repeat tau

Indexed keywords

ISOPROTEIN; TAU PROTEIN;

ADULT; ALTERNATIVE RNA SPLICING; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MALE; MICROTUBULE ASSEMBLY; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; SILENCER GENE; DEMENTIA; DNA SEQUENCE; ELECTRON MICROSCOPY; GENETIC LINKAGE; GENETICS; MIDDLE AGED; PATHOLOGY; PEDIGREE; POINT MUTATION;

ALTERNATIVE SPLICING; APOPTOSIS; DEMENTIA; EXONS; FEMALE; HUMANS; LINKAGE (GENETICS); MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PEDIGREE; POINT MUTATION; SEQUENCE ANALYSIS, DNA; TAU PROTEINS;

EID: 0242317909     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg090     Document Type: Article

References (47)

1. Adamec E, Chang HT, Stopa EG, Hedreen JC, Vonsattel JP. Tau protein expression in frontotemporal dementias. Neurosci Lett 2001; 315: 21-4.
2. Badenhop RF, Moses MJ, Scimone A, Mitchell PB, Ewen KR, Rosso A, et al. A genome screen of a large bipolar affective disorder pedigree supports evidence for a susceptibility locus on chromosome 13q. Mol Psychiatry 2001; 6: 396-403.
3. Baker M, Kwok JB, Kucera S, Crook R, Farrer M, Houlden H, et al. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22. Ann Neurol 1997; 42: 794-8.
4. Broe M, Shepherd CE, Milward EA, Halliday GM. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol (Berl) 2001; 101: 616-24.
5. Buée L, Bussiére T, Buée-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 2000; 33: 95-130.
6. Canu N, Dus L, Barbato C, Ciotti MT, Brancolini C, Rinaldi AM, et al. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 1998; 18: 7061-74.
7. Crowther RA, Goedert M. Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol 2000; 130: 271-9.
8. D'Souza I, Schellenberg GD. Determinants of 4-repeat tau expression: coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J Biol Chem 2000; 275: 17700-9.
9. D'Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM-Y, Bird TD, et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 1999; 96: 5598-603.
10. Dayanandan R, Van Slegtenhorst M, Mack TG, Ko L, Yen SH, Leroy K, et al. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett 1999; 446: 228-32.
11. Fasulo L, Ugolini G, Visintin M, Bradbury A, Brancolini C, Verzillo V, et al. The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J Neurochem 2000; 75: 624-33.
12. Forman MS, Lee VM-Y, Trajanowski JQ. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. J Chem Neuroanat 2000; 20: 225-44.
13. Garcia ML, Cleveland DW. Going new places using old MAP: tau, microtubules and human neurodegenerative disease. Curr Opin Cell Biol 2001; 13: 41-8.
14. Goedert M, Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 1990; 9: 4225-30.
15. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989; 8: 393-9.
16. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992; 8: 159-68.
17. Goedert M, Spillantini MG, Crowther RA, Chen SG, Parchi P, Tabaton M, et al. Tau gene mutation in familial progressive subcortical gliosis. Nat Med 1999; 5: 454-7.
18. Gotz J. Tau and transgenic animal models. Brain Res Brain Res Rev 2001; 35: 266-86.
19. Gotz J, Chen F, Barmettler R, Nitsch RM. Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001; 276: 529-34.
20. Ho L, Xiang Z, Mukherjee P, Zhang W, De Jesus N, Mirjany M, et al. Gene expression profiling of the tau mutant (P301L) transgenic mouse brain. Neurosci Lett 2001; 310: 1-4.
21. Hodges JR, Miller B. The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topics papers: part 1. Neurocase 2001; 7: 31-5.
22. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998; 282: 1914-7.
23. Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, et al. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 1999; 46: 243-8.
24. Hutton M, Lendon C, L., Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-5.
25. Kowalska A, Asada T, Arima K, Kumakini C, Kozubski W, Takahashi K et al. Genetic analysis in patients with familial and sporadic front temperal dementia two-tau mutations in only familial cases and no association with apolipoprotein e4. Dement Geriatr Cogn Disord 2001; 12: 387-92.
26. Kunkel TA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985; 82: 488-92.
27. Lee VM, Wang J, Trojanowski JQ. Purification of paired helical filament tau and normal tau from human brain tissue. Methods Enzymol 1999; 309: 81-9.
28. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001; 24: 1121-59.
29. Lu M, Kosik KS. Competition for microtubule-binding with dual expression of tau missense and splice isoforms. Mol Biol Cell 2001; 12: 171-84.
30. Mack TG, Dayanandan R, Van Slegtenhorst M, Whone A, Hutton M, Lovestone S, et al. Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells. Neuroscience 2001; 108: 701-12.
31. Mann DMA, McDonagh AM, Snowden J, Neary D, Pickering-Brown SM. Molecular classification of the dementias. Lancet 2000; 355: 626.
32. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58: 1803-9.
33. Morris HR, Khan M-N, Janssen JC, Brown JM, Perez-Tur J, Baker M, et al. The genetic and pathological classification of familial frontotemporal dementia. Arch Neurol 2001; 58: 1813-6.
34. Pickering-Brown S, Baker M, Yen SH, Liu WK, Hasegawa M, Cairns N, et al. Pick's disease is associated with mutations in the tau gene. Ann Neurol 2000; 48: 859-67.
35. Pickering-Brown SM, Richardson AMT, Snowden JS, McDonagh AM, Burns A, Braude W, et al. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 2002; 125: 732-51.
36. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, et al. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 2001a; 58: 383-7.
37. Poorkaj P, Kas A, D'Souza I, Zhou Y, Pham Q, Stone M, et al. A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm Genome 2001b; 12: 700-12.
38. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615-21.
39. Rizzu P, Joosse M, Ravid R, Hoogeveen A, Kamphorst W, van Swieten JC, et al. Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients. Hum Mol Genet 2000; 9: 3075-82.
40. Rizzu P, van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, et al. High prevelance of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Human Genet 1999; 64: 414-21.
41. Snowden JS, Neary D, Mann DMA. Frontotemporal dementia. Br J Psychiatry 2002; 180: 140-3.
42. Stanford PM, Halliday GM, Brooks WS, Kwok JBJ, Storey CE, Creasey H, et al. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain 2000; 123: 880-93.
43. Su JH, Nichol KE, Sitch T, Sheu P, Chubb C, Miller BL, et al. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia. Exp Neurol 2000; 163: 9-19.
44. van Slegtenhorst M, Lewis J, Hutton M. The molecular genetics of the tauopathies. Exp Gerontol 2000; 35: 461-71.
45. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001; 293: 711-4.
46. Yen S, Easson C, Nacharaju P, Hutton M, Yen SH. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion. FEBS Lett 1999; 461: 91-5.
47. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M, et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001; 49: 165-75.